Emtriva Oral Solution Generic Name & Formulations
Emtricitabine 10mg/mL; cotton candy flavor.
Nucleoside analogue (reverse transcriptase inhibitor).
Emtriva Oral Solution Indications
HIV-1 infection, in combination with other antiretroviral agents.
Emtriva Oral Solution Dosage and Administration
≥18yrs: 240mg (24mL) once daily. Renal impairment: (CrCl 30–49mL/min): 120mg (12mL) once daily; (CrCl 15–29mL/min): 80mg (8mL) once daily; (CrCl <15mL/min or dialysis): 60mg (6mL) once daily.
<3mos: 3mg/kg once daily. 3mos–17yrs: 6mg/kg [max 240mg (24mL)] once daily. >33kg: may use cap form. Renal impairment: reduce dose or prolong dosing interval (see full labeling).
Emtriva Oral Solution Contraindications
Emtriva Oral Solution Boxed Warnings
Posttreatment exacerbation of hepatitis B.
Emtriva Oral Solution Warnings/Precautions
Not for treating chronic HBV infection; test for HBV before starting therapy and closely monitor patients co-infected with HBV and HIV for several months after stopping treatment (discontinuing therapy may exacerbate HBV infection); if appropriate, initiate anti-hepatitis B therapy may be warranted. Suspend therapy if lactic acidosis or hepatotoxicity (eg, hepatomegaly, steatosis) occurs. Renal impairment. Pregnancy (Cat.B). Nursing mothers: not recommended.
Emtriva Oral Solution Pharmacokinetics
Emtriva Oral Solution Interactions
Avoid concomitant drugs that contain emtricitabine or lamivudine (eg, fixed dose combination products).
Emtriva Oral Solution Adverse Reactions
Headache, diarrhea, nausea, fatigue, dizziness, depression, insomnia, abnormal dreams, rash, abdominal pain, asthenia, increased cough, rhinitis; new onset or worsening renal impairment, immune reconstitution syndrome; also children: skin hyperpigmentation.
Emtriva Oral Solution Clinical Trials
Emtriva Oral Solution Note
Register pregnant patients exposed to emtricitabine by calling (800) 258-4263.
Emtriva Oral Solution Patient Counseling